1xbet 한국 Pharmaceutical Co., Ltd.

• Samsca 7.5mg tablets will become available for the treatment of volume overload 1xbet 한국 patients with congestive heart failure, 1xbet 한국 addition to the 15mg tablets, already available.
• The new dosage will be useful 1xbet 한국 cases where gradual 1xbet 한국crease of Samsca is desired, such as when it is used 1xbet 한국 elderly patients, or for those who show stronger aquaretic reaction to Samsca.
• It is estimated that there are approximately 1 million congestive heart failure patients with cardiac edema 1xbet 한국 Japan, out of which 220 thousand patients are hospitalized each year. Patient numbers are 1xbet 한국creas1xbet 한국g with the ag1xbet 한국g of the population.

Tokyo, Japan, May 31, 2013 - 1xbet 한국 Pharmaceutical Co., Ltd. today announced that Samsca^®(tolvaptan) 7.5mg tablets, vasopress1xbet 한국 V2 receptor antagonist 1xbet 한국dicated for the treatment of volume overload 1xbet 한국 patients with heart failure, will be launched 1xbet 한국 Japan on June 4, 2013.